MedPath

Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study

Completed
Conditions
Functional Psychoses
Informal Caregivers
Registration Number
NCT00670371
Lead Sponsor
AstraZeneca
Brief Summary

The objective is to find determinants for the subjective and objective burden of informal caregivers to patients who are requiring continued antipsychotic treatment for functional psychoses among factors related to the patient, the health care and support provision system and the informal caregiver him/her-self.

Detailed Description

The study also comprises a descriptive part with the aim:

* To describe clinical characteristics, symptoms, and functioning in the patient group.

* To describe patient resource use in terms of support from the health care and social care sector.

* To describe the socio-economic situation, the general and psychological health, and the coping ability of the informal caregivers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Provision of informed consent
  • Patients, male or female, aged 18 years or more, suffering or having suffered from a psychotic episode and being in need of continuous antipsychotic medication.
  • The respective patient must have at least one informal caregiver.
  • Subjects (patients and informal caregivers) must be able to read and write.
Read More
Exclusion Criteria
  • Diagnosis of dementia and such cognitive impairment which makes self assessments even with assistance unreliable (patients and informal caregivers).
  • Involvement in the planning and conduct of the study (patients and informal caregivers).
  • Other concurrent medical condition interfering with ability to complete study (patients and informal caregivers).
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Research Site

🇸🇪

Stockholm, Sweden

Research site

🇸🇪

Bromma, Sweden

© Copyright 2025. All Rights Reserved by MedPath